Duran-Nebreda S, Bassel G (July 2017). "Fluorescein Transport Assay to Assess Bulk Flow of Molecules Through the Hypocotyl in Arabidopsis thaliana". Bio-Protocol8 (7): e2791. doi:10.21769/bioprotoc.2791.
Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999). "Fatal anaphylactic shock during a fluorescein angiography". Forensic Sci. Int.100 (1–2): 137–42. PMID10356782. doi:10.1016/S0379-0738(98)00205-9.
Hitosugi M, Omura K, Yokoyama T, Kawato H, Motozawa Y, Nagai T, Tokudome S (2004). "An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report". Med Sci Law44 (3): 264–5. PMID15296251. doi:10.1258/rsmmsl.44.3.264.
Gómez-Ulla F, Gutiérrez C, Seoane I (1991). "Severe anaphylactic reaction to orally administered fluorescein". Am. J. Ophthalmol.112 (1): 94. PMID1882930. doi:10.1016/s0002-9394(14)76222-1.
Kwan AS, Barry C, McAllister IL, Constable I (2006). "Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience". Clin. Experiment. Ophthalmol.34 (1): 33–8. PMID16451256. doi:10.1111/j.1442-9071.2006.01136.x.
Yang CS, Sung CS, Lee FL, Hsu WM (2007). "Management of anaphylactic shock during intravenous fluorescein angiography at an outpatient clinic". J Chin Med Assoc70 (8): 348–9. PMID17698436. doi:10.1016/S1726-4901(08)70017-0.
Sun, W. C.; Gee, K. R.; Klaubert, D. H.; Haugland, R. P. (1997). "Synthesis of Fluorinated Fluoresceins". The Journal of Organic Chemistry62 (19): 6469–6475. doi:10.1021/jo9706178.
Burgess, Kevin; Ueno, Yuichiro; Jiao, Guan-Sheng (2004). "Preparation of 5- and 6-Carboxyfluorescein". Synthesis2004 (15): 2591–2593. doi:10.1055/s-2004-829194.
El Harrar, N; Idali, B; Moutaouakkil, S; El Belhadji, M; Zaghloul, K; Amraoui, A; Benaguida, M (1996). "Anaphylactic shock caused by application of fluorescein on the ocular conjunctiva". Presse Médicale25 (32): 1546–7. PMID8952662.
Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999). "Fatal anaphylactic shock during a fluorescein angiography". Forensic Sci. Int.100 (1–2): 137–42. PMID10356782. doi:10.1016/S0379-0738(98)00205-9.
Hitosugi M, Omura K, Yokoyama T, Kawato H, Motozawa Y, Nagai T, Tokudome S (2004). "An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report". Med Sci Law44 (3): 264–5. PMID15296251. doi:10.1258/rsmmsl.44.3.264.
Gómez-Ulla F, Gutiérrez C, Seoane I (1991). "Severe anaphylactic reaction to orally administered fluorescein". Am. J. Ophthalmol.112 (1): 94. PMID1882930. doi:10.1016/s0002-9394(14)76222-1.
Kwan AS, Barry C, McAllister IL, Constable I (2006). "Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience". Clin. Experiment. Ophthalmol.34 (1): 33–8. PMID16451256. doi:10.1111/j.1442-9071.2006.01136.x.
Jennings BJ, Mathews DE (1994). "Adverse reactions during retinal fluorescein angiography". J Am Optom Assoc65 (7): 465–71. PMID7930354.
Matsuura M, Ando F, Fukumoto K, Kyogane I, Torii Y, Matsuura M (1996). "[Usefulness of the prick test for anaphylactoid reaction in intravenous fluorescein administration]". Nippon Ganka Gakkai Zasshi(en Japanese)100 (4): 313–7. PMID8644545.
Yang CS, Sung CS, Lee FL, Hsu WM (2007). "Management of anaphylactic shock during intravenous fluorescein angiography at an outpatient clinic". J Chin Med Assoc70 (8): 348–9. PMID17698436. doi:10.1016/S1726-4901(08)70017-0.
patents.google.com
Brush, C. K. "Fluorescein Labelled Phosphoramidites". US Patent 5583236. Priority date July 19, 1991.